Verition Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
|
|||||
|
2025
Q1 | $6.42M | Sell |
|
|||||
|
2024
Q4 | $7.58M | Buy |
|
|||||
|
2024
Q3 | $6.09M | Buy |
|
|||||
|
2024
Q2 | $4.09M | Sell |
|
|||||
|
2024
Q1 | $8.58M | Buy |
|
|||||
|
2023
Q4 | $4.13M | Buy |
|
|||||
|
2023
Q3 | $961K | Buy |
|
|||||
|
2023
Q2 | $691K | Hold |
|
|||||
|
2023
Q1 | $619K | Sell |
|
|||||
|
2022
Q4 | $10.3M | Sell |
|
|||||
|
2022
Q3 | $16.6M | Buy |
|
|||||
|
2022
Q2 | $10.3M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.15M | Sell |
|
|||||
|
2021
Q3 | $3.21M | Buy |
|
|||||
|
2021
Q2 | $831K | Buy |
|
|||||
|
2021
Q1 | $480K | Buy |
|
|||||
|
2020
Q4 | $209K | Sell |
|
|||||
|
2020
Q3 | $314K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.76M | Buy |
|
|||||
|
2019
Q3 | $491K | Sell |
|
|||||
|
2019
Q2 | $705K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.34M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $449K | Sell |
|
|||||
|
2017
Q2 | $476K | Buy |
|
|||||
|
2017
Q1 | $372K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $205K | Sell |
|
|||||
|
2016
Q1 | $1.14M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $263K | Buy |
|
|||||
|
2015
Q2 | $208K | Sell |
|
|||||
|
2015
Q1 | $220K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $298K | Buy |
|